Matthews South

Matthews South

  • About Us
  • Our Solutions
    • Debt
    • Equity
    • IPO
    • Pre-IPO Financing
    • Convertible & Call Spread
      • Call Spread Unwind
      • Liability Management
    • Share Repurchases
      • Accelerated Share Repurchase (ASR)
      • Enhanced Open Market Repurchase (eOMR)
    • Capital Structure Review
  • Our Clients
    • Client List
    • Testimonials
  • Our Team
  • Video Library
  • Blog
  • Contact Us
  • Login

OUR BLOG

Convertible Issuance in Life Sciences: How, When and Why

by Kristina Woodhouse | June 22, 2022 | Biotech, Convertible, Financing, Healthcare, Post-IPO

In the first installment of our three-part series on the financing landscape for life sciences issuers, we covered the evolution of the typical life sciences IPO.  In the second installment, we covered post-IPO financing dynamics and the importance of laying the foundation for successful capital ... >>>Read More

Are the Financing Markets Really Open? – An Examination of the US Equity, Convertible, High Yield, and Investment Grade Markets in Spring 2022

by Bryan Goldstein | June 9, 2022 | Convertible, Equity, Financing, Market Review

With Federal Reserve tightening and geopolitical uncertainty rising in the last few months, we have seen gains accumulated during COVID dissipate since the start of the year.  Consequently, US secondary markets have caused drastic shifts in primary issuance behavior in each of the major financing ... >>>Read More

Convertible 101 for Beginners

by Kristina Woodhouse | April 27, 2022 | Convertible

As a courtesy for those who may not have prior experience with convertible bonds, we provide some background information on some general questions. What are convertible offerings? Convertible offerings are sales of securities convertible into equity (generally common stock) of public ... >>>Read More

Q1 2022 Convertible Market Review

by Jake Levine | April 19, 2022 | Convertible, Market Review

As part of our market update series, please see the summary below of what we saw in the convertible market in Q1 2022.   New Issuance.  Q1 2022 saw 11 new issue convertible deals (all debt) with a total volume of $6.1bn, which marks the lowest level of issuance since Q4 2018 ($5.3bn across 16 ... >>>Read More

Q4 2021 Convertible Market Review

by Jake Levine | January 10, 2022 | Convertible, Market Review

As part of our market update series, please see the summary below of what we saw in the convertible market in Q4 2021.   New Issuance.  Q4 2021 saw 27 new issue convertible deals (all debt) with a total volume of $18.1bn, which brought total 2021 issuance to $92.8bn across 155 deals.  2021 was the ... >>>Read More

  • 1
  • 2
  • 3
  • …
  • 10
  • Next Page »

Recent Posts

  • Convertible Issuance in Life Sciences: How, When and Why
  • Are the Financing Markets Really Open? – An Examination of the US Equity, Convertible, High Yield, and Investment Grade Markets in Spring 2022
  • Share Buyback 101 for Beginners
  • Post-IPO Financing Dynamics: How to Lay the Foundation for Successful Capital Raises
  • Share Repurchase Strategy: Are Pre-paid Puts Attractive in the Current Market?

Archives

Categories

  • ASR
  • Biotech
  • Buyback
  • Convertible
  • COVID-19
  • Crossover
  • eOMR
  • Equity
  • Financing
  • Healthcare
  • IPO
  • IPO Advisory
  • Market Review
  • OMR
  • Post-IPO
  • Pre-IPO
  • Software
  • SPAC

Contact Us

To learn more about our solutions or to schedule a demo of our software, please contact us by filling out the form below, or email us at info@matthewssouth.com.






    • Matthews South LLC is a member of FINRA and SIPC
    • Brokercheck
    • © Matthews South, Inc. 2021
    • Privacy Policy
    • Additional Disclosure
    • Testimonials may not be representative of the experience of other customers and are not a guarantee of future performance or success